Teva-Enoxaparin-Momenta & Sandoz


On december 02, 2010, Momenta and Sandoz sued Teva for patent infringement of its US FDA pending enoxaparin ANDA. Sanofi Aventis is innovator for enoxaparin and Sandoz has recently received approval of its ANDA. Sandoz has developed enoxaparin ANDA product in alliance with Momenta pharma

Momenta has sued Teva on 7,575,886 (the “‘886 patent”) and 7,790,466 (the “‘466 patent”). Teva in press release, said its ANDA product is manufactured and tested outside US and ANDA is not yet approved by US FDA for marketing and Teva will not infringe these patent before approval.

View on RFC and Teva Press Release [Complaint copy]

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Patent case and tagged , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s